Pilot and definitive studies to evaluate Insertional Mutagenesis

评估插入诱变的试点和最终研究

基本信息

  • 批准号:
    8655051
  • 负责人:
  • 金额:
    $ 42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-02-03 至 2014-02-02
  • 项目状态:
    已结题

项目摘要

The goal of this contract is to provide support of National Toxicology Program (NTP) hazard identification activities targeted toward the prevention of diseases or adverse effects caused by environmental exposure to chemical or physical agents. Toxicity testing is an important aspect of public health research in that it serves to identify chemicals that are hazardous to human health. Proper chemical analyses are required to ensure that, in toxicity studies, the test species are exposed to the prescribed chemicals at the specified dose concentrations. These contracts contribute to the ability of toxicity studies to provide evidence of heightened cancer risk along with other toxicological outcomes, by providing characterization of the chemicals studied, confirmation of the dose levels administered, and internal dose determinations. This information is critical to evaluation of toxicity tests and development of sound, scientific conclusions about the potential toxicity of the study chemical in the test species and ultimately supports the risk assessment efforts of National Toxicology Program and other federal agencies. With internal dose information provided by this contract, extrapolations to humans can be made so that the public can be adequately informed about risk factors arising from exposure to studied chemicals.
该合同的目的是为国家毒理学计划(NTP)的危害识别活动提供支持,这些活动旨在预防因环境暴露于化学或物理制剂而引起的疾病或不良影响。毒性测试是公共卫生研究的一个重要方面,因为它有助于确定对人类健康有害的化学品。需要进行适当的化学分析,以确保在毒性研究中,试验种属以规定的剂量浓度暴露于规定的化学品。这些合同通过提供所研究化学品的特征、所施用剂量水平的确认和内部剂量确定,有助于毒性研究提供癌症风险升高沿着其他毒理学结果的证据。这些信息对于评价毒性试验和得出关于研究化学品在试验种属中的潜在毒性的合理科学结论至关重要,并最终支持国家毒理学计划和其他联邦机构的风险评估工作。根据该合同提供的内部剂量信息,可以对人类进行推断,以便公众能够充分了解接触所研究的化学品所产生的风险因素。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LU TAYLOR其他文献

LU TAYLOR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LU TAYLOR', 18)}}的其他基金

Toxicity study of n-butylbenzenesulfonamide (NBBS)
正丁基苯磺酰胺(NBBS)的毒性研究
  • 批准号:
    8845111
  • 财政年份:
    2005
  • 资助金额:
    $ 42万
  • 项目类别:
Toxicity Study of the Ionic Liquids
离子液体的毒性研究
  • 批准号:
    8655055
  • 财政年份:
    2005
  • 资助金额:
    $ 42万
  • 项目类别:
Studies to Evaluate Cardiotoxic Disease Process in Three Strains of Mice Exposed
评估三种暴露小鼠品系的心脏毒性疾病过程的研究
  • 批准号:
    8428969
  • 财政年份:
    2005
  • 资助金额:
    $ 42万
  • 项目类别:
Age Related Survival and Spontaneous Disease Phenotype in Selected Genetically Di
选定遗传疾病中年龄相关的生存和自发性疾病表型
  • 批准号:
    8845105
  • 财政年份:
    2005
  • 资助金额:
    $ 42万
  • 项目类别:
TAS::75 0862::TAS - NTP TOXICOLOGIC POTENTIAL OF SELECTED TEST AGENTS
TAS::75 0862::TAS - 所选测试剂的 NTP 毒理学潜力
  • 批准号:
    8338928
  • 财政年份:
    2005
  • 资助金额:
    $ 42万
  • 项目类别:
TAS::75 0862::TAS - NTP TOXICOLOGIC POTENTIAL OF SELECTED TEST AGENTS
TAS::75 0862::TAS - 所选测试剂的 NTP 毒理学潜力
  • 批准号:
    8338931
  • 财政年份:
    2005
  • 资助金额:
    $ 42万
  • 项目类别:
Pilot and definitive studies to evaluate Insertional Mutagenesis
评估插入诱变的试点和最终研究
  • 批准号:
    8428966
  • 财政年份:
    2005
  • 资助金额:
    $ 42万
  • 项目类别:
Toxicity Study of the Serotype 2 Adeno-Associated Viral Vector hAQP1(rAAV2hAQP1)
血清2型腺相关病毒载体hAQP1(rAAV2hAQP1)的毒性研究
  • 批准号:
    8428970
  • 财政年份:
    2005
  • 资助金额:
    $ 42万
  • 项目类别:
Microarray Analysis of Rat Liver Samples
大鼠肝脏样本的微阵列分析
  • 批准号:
    8655052
  • 财政年份:
    2005
  • 资助金额:
    $ 42万
  • 项目类别:
Toxicity Study of the Perflourinated compounds
全氟化合物的毒性研究
  • 批准号:
    8428971
  • 财政年份:
    2005
  • 资助金额:
    $ 42万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 42万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 42万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 42万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 42万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 42万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 42万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 42万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 42万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了